133 related articles for article (PubMed ID: 36947987)
1. Myosteatotic and sarcopenic obesity impact postoperative outcomes more robustly than visceral obesity in general surgery patients, with differences by sex.
Jones A; Silver HJ
Clin Nutr; 2023 May; 42(5):625-635. PubMed ID: 36947987
[TBL] [Abstract][Full Text] [Related]
2. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
[TBL] [Abstract][Full Text] [Related]
3. Tumour grade and stage are associated with specific body composition phenotypes with visceral obesity predisposing the host to a less aggressive tumour in colorectal cancer.
Pring ET; Malietzis G; Gould LE; Lung P; Drami I; Athanasiou T; Jenkins JT
Eur J Surg Oncol; 2022 Jul; 48(7):1664-1670. PubMed ID: 35339340
[TBL] [Abstract][Full Text] [Related]
4. The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases.
Runkel M; Diallo TD; Lang SA; Bamberg F; Benndorf M; Fichtner-Feigl S
World J Surg; 2021 Jul; 45(7):2218-2226. PubMed ID: 33842995
[TBL] [Abstract][Full Text] [Related]
5. Associations of body composition parameters with postoperative outcome and perineural tumour invasion after oncological pancreatic resection.
Mueller TC; Henselmann M; Reischl S; Jaeger C; Trefzer C; Demir IE; Friess H; Martignoni ME
BMC Surg; 2024 Jun; 24(1):175. PubMed ID: 38835067
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI.
Jang M; Park HW; Huh J; Lee JH; Jeong YK; Nah YW; Park J; Kim KW
Eur Radiol; 2019 May; 29(5):2417-2425. PubMed ID: 30406311
[TBL] [Abstract][Full Text] [Related]
7. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
8. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
9. Impact of sarcopenic obesity on 30-day mortality in critically ill patients with intra-abdominal sepsis.
Ji Y; Cheng B; Xu Z; Ye H; Lu W; Luo X; Fu S; Fang X
J Crit Care; 2018 Aug; 46():50-54. PubMed ID: 29677586
[TBL] [Abstract][Full Text] [Related]
10. Impact of sarcopenia on the surgical outcomes in patients with hepatolithiasis: A multicenter 10-year experience.
Wang T; Chen X; Liao C; Wang D; Huang L; Li G; Chen J; Lin C; Wang L; Pan J; Zhang C; Zhou S; Qiu F; Wang Y; Zhang Z; Chen Y; Zheng X; Tian Y; Chen S
Surgery; 2022 Dec; 172(6):1712-1721. PubMed ID: 36280506
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease.
Grillot J; D'Engremont C; Parmentier AL; Lakkis Z; Piton G; Cazaux D; Gay C; De Billy M; Koch S; Borot S; Vuitton L
Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183
[TBL] [Abstract][Full Text] [Related]
13. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
14. Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer.
Pedrazzani C; Conti C; Zamboni GA; Chincarini M; Turri G; Valdegamberi A; Guglielmi A
Clin Nutr; 2020 Dec; 39(12):3763-3770. PubMed ID: 32336524
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for digestive tract cancer: A prospective cohort study.
Zhang S; Tan S; Jiang Y; Xi Q; Meng Q; Zhuang Q; Han Y; Sui X; Wu G
Clin Nutr; 2019 Dec; 38(6):2881-2888. PubMed ID: 30630709
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients.
Martin L; Gioulbasanis I; Senesse P; Baracos VE
JPEN J Parenter Enteral Nutr; 2020 Feb; 44(2):227-238. PubMed ID: 31012128
[TBL] [Abstract][Full Text] [Related]
18. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
[TBL] [Abstract][Full Text] [Related]
19. Identification of sarcopenic obesity in adults undergoing orthopaedic surgery: Relationship between "a body shape index" (ABSI) and fat-free mass. A cross -sectional study.
Tomažič A; Žvanut B; Grbac LV; Jurdana M
PLoS One; 2022; 17(6):e0269956. PubMed ID: 35731798
[TBL] [Abstract][Full Text] [Related]
20. CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma.
Fehrenbach U; Wuensch T; Gabriel P; Segger L; Yamaguchi T; Auer TA; Beetz NL; Denecke C; Kröll D; Raakow J; Knitter S; Chopra S; Thuss-Patience P; Pratschke J; Hamm B; Biebl M; Geisel D
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
